CG
VYNT

Cutler Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Cutler Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3
Closed -$1.56K – 6976
2017
Q2 		$1K Sell
3
-3
-50% -$1.75K ﹤0.01% 6114
2017
Q1 		$3K Sell
6
-4
-40% -$1.42K ﹤0.01% 5270
2016
Q4 		$2K Hold
10
– – ﹤0.01% 5756
2016
Q3 		$2K Hold
10
– – ﹤0.01% 5864
2016
Q2 		$2K Buy
10
+3
+43% +$1.05K ﹤0.01% 5822
2016
Q1 		$2K Sell
7
-2
-22% -$748 ﹤0.01% 5729
2015
Q4 		$4K Buy
+9
New +$6.5K ﹤0.01% 5149

Other funds holding VYNT

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Cutler Group's VYNT Position: Q3 2017 in Review

Cutler Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2017, closing a stake of 3 shares — an estimated $1.56K sold.

Cutler Group first reported a position in VYNT in Q4 2015 and held it in 7 quarters. The position peaked at $4K in Q4 2015. 26 funds tracked by Wall St. Rank hold VYNT as of Q3 2017.

  • Cutler Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 3 Vyant Bio, Inc. Common Stock shares in Q3 2017, an estimated $1.56K.
  • Cutler Group first reported a position in Vyant Bio, Inc. Common Stock in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Vyant Bio, Inc. Common Stock position peaked at $4K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.